Transcranial magnetic stimulation in obsessive compulsive disorder: a double-blind, cross over, placebo-controlled trial

被引：2
|
作者：
Ziblak, A. [1 ]
Tumkaya, S. [1 ]
Kashyap, H. [2 ]
机构：
[1] Pamukkale Univ, Psychiat, Denizli, Turkey
[2] NIMHANS, Clin Psychol, Bengaluru, India
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.euroneuro.2019.12.099
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.402
引用
收藏
页码：S75 / S76
页数：3
相关论文
共 50 条
  • [41] Paroxetine in the treatment of obsessive-compulsive disorder: randomized, double-blind, placebo-controlled study in Japanese patients
    Kamijima, K
    Murasaki, M
    Asai, M
    Higuchi, T
    Nakajima, T
    Taga, C
    Matsunaga, H
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2004, 58 (04) : 427 - 433
  • [42] N-Acetylcysteine Add-On Treatment in Refractory Obsessive-Compulsive Disorder A Randomized, Double-Blind, Placebo-Controlled Trial
    Afshar, Hamid
    Roohafza, Hamidreza
    Mohammad-Beigi, Hamid
    Haghighi, Mohammad
    Jahangard, Leila
    Shokouh, Pedram
    Sadeghi, Masoumeh
    Hafezian, Hasan
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2012, 32 (06) : 797 - 803
  • [43] Aripiprazole as an adjuvant treatment for obsessive and compulsive symptoms in manic phase of bipolar disorder: A randomized, double-blind, placebo-controlled clinical trial
    Sahraian, Ali
    Ehsaei, Zahra
    Mowla, Arash
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2018, 84 : 267 - 271
  • [44] Double-Blind, Placebo-Controlled, Pilot Trial of Paliperidone Augmentation in Serotonin Reuptake Inhibitor-Resistant Obsessive-Compulsive Disorder
    Storch, Eric A.
    Goddard, Andrew W.
    Grant, Jon E.
    De Nadai, Alessandro S.
    Goodman, Wayne K.
    Mutch, P. Jane
    Medlock, Carla
    Odlaug, Brian
    McDougle, Christopher J.
    Murphy, Tanya K.
    JOURNAL OF CLINICAL PSYCHIATRY, 2013, 74 (06) : E527 - E532
  • [45] A double-blind, randomized, placebo-controlled trial of quetiapine addition in patients with obsessive-compulsive disorder resistant to serotonin reuptake inhibitors
    Denys, D
    Westenberg, H
    BIOLOGICAL PSYCHIATRY, 2004, 55 : 189S - 190S
  • [46] A double-blind, randomized, placebo-controlled trial of quetiapine augmentation in patients with obsessive-compulsive disorder resistant to serotonin reuptake inhibitors
    Denys, D
    De Geus, E
    Van Megen, H
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S361 - S361
  • [47] A double-blind, randomized, placebo-controlled trial of quetiapine addition in patients with obsessive-compulsive disorder refractory to serotonin Reuptake inhibitors
    Denys, D
    de Geus, F
    van Megen, HJGM
    Westenberg, HGM
    JOURNAL OF CLINICAL PSYCHIATRY, 2004, 65 (08) : 1040 - 1048
  • [48] Minocycline combination therapy with fluvoxamine in moderate-to-severe obsessive-compulsive disorder: A placebo-controlled, double-blind, randomized trial
    Esalatmanesh, Sophia
    Abrishami, Zoha
    Zeinoddini, Atefeh
    Rahiminejad, Fatemeh
    Sadeghi, Majid
    Najarzadegan, Mohammad-Reza
    Shalbafan, Mohammad-Reza
    Akhondzadeh, Shahin
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2016, 70 (11) : 517 - 526
  • [49] Randomized, Double-Blind, Placebo-Controlled Trial of N-Acetylcysteine Augmentation for Treatment-Resistant Obsessive-Compulsive Disorder
    Costa, Daniel L. C.
    Diniz, Juliana B.
    Requena, Guaraci
    Joaquim, Marines A.
    Pittenger, Christopher
    Bloch, Michael H.
    Miguel, Euripedes C.
    Shavitt, Roseli G.
    JOURNAL OF CLINICAL PSYCHIATRY, 2017, 78 (07) : E766 - +
  • [50] A double-blind, randomized, placebo-controlled trial of quetiapine augmentation in patients with obsessive-compulsive disorder resistant to serotonin reuptake inhibitors
    Denys, D
    de Geus, E
    van Megen, H
    Westenberg, H
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S196 - S196
12345